Navigation Links
Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
Date:8/15/2011

ients with HIBM typically begin to have weakness and abnormal walking at 18 to 30 years of age. Over the ensuing 10 to 20 years, many patients progressively lose significant functional ability and become wheelchair-bound. There are no current treatments for HIBM.

UX001 is an extended release formulation of sialic acid that should allow the maintenance of steady levels of sialic acid after oral administration. The sialic acid replacement therapy is expected to restore the proper biochemistry of glycoproteins and glycolipids by allowing proper sialylation.  Data from an HIBM mouse model show a profound beneficial effect of sialic acid replacement therapy on the biochemistry, pathology and clinical outcomes of HIBM mice.

About Ultragenyx

Ultragenyx is a private, clinical-stage biotechnology company committed to developing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases. Ultragenyx is leveraging its experience in orphan indications to identify target diseases with well understood biological mechanisms to generate a pipeline of promising treatments for medically underserved patient populations. Ultragenyx' lead program, UX001, is currently being evaluated in a Phase 1 trial in hereditary inclusion body myopathy (HIBM).

Ultragenyx aspires to create a new model for successful rare disease drug development and to deliver significant value to all its key stakeholders by rapidly and efficiently transforming good science into great medicines for untreated rare diseases. Ultragenyx' investors include TPG Biotech and Fidelity Biosciences, HealthCap and Pappas Ventures. The company is led by Emil Kakkis, MD, PhD, a recognized industry leader in rare disease research and development.

For more information on Ultragenyx, please visit the company's website at www.ultragenyx.com.


'/>"/>
SOURCE Ultragenyx Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. American Regent, Inc. Initiates Voluntary Recall of Seventeen Lots of Vasopressin Injection, USP, Multiple Dose Vials due to Sub-Potency
2. Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes
3. American Regent Initiates Voluntary Nationwide Recall of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package Due to Particulates
4. EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown
5. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
7. Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
8. Cebix Initiates Phase 1b Clinical Trial with Drug Candidate Ersatta™
9. American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates
10. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
11. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015  Excite Medical was established by ... the years, Excite Medical, under the leadership of ... company, with a solid track record of providing unparalleled ... and distributor base.  Photo - ... Medical has been possible, in large part, due to ...
(Date:5/29/2015)... , May 28, 2015 Research and Markets ... "North America MRI Market - Growth, Trends And ... The North American MRI systems market is ... 2014 to $1.58 billion by 2020 with a CAGR ... of three types namely, the open system, closed system ...
(Date:5/29/2015)... , May 29, 2015 A six-hour certification program ... being presented at the Cannabis World Congress & Business ... New York, NY .  Taking place on Wednesday, June ... day of education at the leading event on the East ... Led by Clover Leaf University, the first cannabis university ...
Breaking Medicine Technology:North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4
... 6, 2012 HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) ... results for the three and 12 months ended December ... on Thursday, February 16, 2012 (being midnight Australian Eastern ... The Company plans to release the financial results prior ...
... GRAND RAPIDS, Mich., Feb. 6, 2012  A recent discovery ... prediction of patient sensitivity to proposed drug therapies for ... brain tumor in humans. The study, published ... National Academy of Science , investigated glioblastoma models ...
Cached Medicine Technology:HeartWare Schedules Fourth Quarter Conference Call and Webcast 2Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer 2
(Date:5/30/2015)... Cyclist Barry Haarde will commence his ... 2015: Piles of Miles” near San Francisco, California ... and encourage individuals to support needy hemophilic children ... Life supports nearly 1,200 impoverished children and adults ... sponsorships, scholarships and micro-enterprise grants. Hemophilia is a ...
(Date:5/30/2015)... May 30, 2015 This year the ... with Pulmonary Horizons to offer one of the most ... and discuss successful practices to diagnose, treat and manage ... Pulmonary Horizons Conference is Interaction with Multidisciplinary ... the Overall Needs of Patients with COPD," said Brian ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 ... leap forward in Los Angeles thanks to the efforts ... Dr. Mohebi has combined ARTAS hair restoration ... most advanced hair restoration procedures available anywhere. , A ... of directly and individually harvesting hair follicle grafts from ...
(Date:5/29/2015)... PALMER LAKE, CO (PRWEB) May 29, 2015 ... a brand new addiction, substance abuse, and co-occurring ... Opening celebration and ribbon cutting for the general ... patients June 2nd. , The Recovery Village at ... hospitalization, and intensive outpatient programming, utilizing traditional and ...
Breaking Medicine News(10 mins):Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2
... to Help Hospitals Become SustainableARLINGTON, Va., Feb. 2 ... which will be new clean energy jobs, could ... Renewable Energy and Green Healthcare Jobs Initiative ... Health Care Without Harm, Practice Greenhealth and Global ...
... AMDL, Inc. (NYSE,Alternext US: ADL), a vertically integrated ... today its Chairman and CEO Mr.,Douglas MacLellan will appear ... a.m.,PT) today, February 2, 2009. , ... on Fox Business News to,discuss the current business environment ...
... Becomes First Life Sciences Organization Attracted to Florida to Open its ... ... St. Lucie, FL (Vocus) February 2, 2009 -- More than 200 ... Torrey Pines Institute for Molecular Studies, (TPIMS) headquarters in ...
... to serve Healthcare Industry , ... ... Solutions LLC today announced partnerships with several leading online ... geoMEDICX Zip+4 and Zip code targeting tags and offer ...
... Susan Cordts , ... Denver, CO (PRWEB) February 2, ... Inc. (ATi) recently participated in an exclusive interview with Mary Jo ... explains how ATi solutions predict who to target with what product, ...
... psychologists, geneticists and neuroscientists has reported that a safe ... the brain has improved spatial learning and working memory ... human use of the drug, the finding supports the ... cognitive impairment, cushion the cognitive impact of normal aging, ...
Cached Medicine News:Health News:Healthcare Sector Leaders Urge Obama, Congress to Invest in Alternative Energy and Green Jobs in Healthcare 2Health News:Healthcare Sector Leaders Urge Obama, Congress to Invest in Alternative Energy and Green Jobs in Healthcare 3Health News:AMDL Chairman & CEO Mr. Douglas MacLellan Featured on Fox Business News Monday February 2, 2009 2Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 2Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 3Health News:Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media 2Health News:Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media 3Health News:ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates 2Health News:ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates 3Health News:Vascular drug found to improve learning and memory in middle-aged rats 2
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... EVLT, the #1 physician choice in ... advantages to remedying superficial vein reflux. EVLT ... to surgical vein stripping that effectively and ... laser fiber to occlude the vein. The ...
... than 1 million people are diagnosed with ... of these patients never seek treament and ... System can offer them an effective alternative ... (stab avulsion or hook phlebectomy), is considered ...
Medicine Products: